ADVIK LABORATORIES LTD. Share Price

ADVIK LABORATORIES LTD. Share Price

BSE: 531686
|
Pharmaceuticals
|
S Cap
₹ 1.99
+0.00 (0.00%)
1D
Last updated 17 Aug, 2026, 14:50 IST

ADVIK LABORATORIES LTD. Share Price Today

As of 22 Aug 2026, ADVIK LABORATORIES LTD. share price is ₹1.99. The stock opened at ₹1.99, compared to its previous close of ₹1.99. During today's trading session, ADVIK LABORATORIES LTD. share price moved in the range of ₹1.99 to ₹1.99, with an average price of ₹1.99 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.57 and a high of ₹2.46.

₹1.99
0.00% up today
₹1.99
1D LOW
1D HIGH

ADVIK LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹1.90
₹1.99
52-week
L
H
₹1.57
₹2.46

About ADVIK LABORATORIES LTD.

ADVIK LABORATORIES LTD. Share Price
ISIN
INE537C01019
Sector Market Cap
₹ 3.8 Cr

ADVIK LABORATORIES LTD. Financial Highlights

  • Revenue: ADVIK LABORATORIES LTD. reported revenue of ₹0.04 crore in FY26 vs ₹0.05 crore in FY25. It showed a decrease of 20.00% on a yearly basis.
  • Operating Profit: ADVIK LABORATORIES LTD. reported an operating loss of ₹1.06 crore in FY26 vs ₹0.86 crore in FY25. It showed a decrease of 23.26% on a year-on-year basis.
  • Net Profit: ADVIK LABORATORIES LTD. reported a net loss of ₹1.02 crore in FY26 vs ₹0.90 crore in FY25. It showed a decrease of 13.33% on a yearly basis.

ADVIK LABORATORIES LTD. Quarterly Result Highlights

  • ADVIK LABORATORIES LTD. reported revenue of ₹0.00 crore in Jun 2026, compared with ₹0.04 crore in Mar 2026, representing a decrease of 100.00% on a quarter-on-quarter (QoQ) basis.
  • ADVIK LABORATORIES LTD. reported an operating loss of ₹0.24 crore in Jun 2026, compared with ₹0.37 crore in Mar 2026, representing an increase of 35.14% on a quarter-on-quarter (QoQ) basis.
  • ADVIK LABORATORIES LTD. reported a loss of ₹0.24 crore in Jun 2026, compared with ₹0.36 crore in Mar 2026, reflecting an increase of 33.33% on a QoQ basis.
  • The earnings per share (EPS) of ADVIK LABORATORIES LTD. stood at ₹0.47 during Jun 2026.
Know more
Promoters
35.89%
FII
0.00%
Other DII
0.58%
Retail and other
63.53%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
3.80
P/E
-3.69
P/B
53.27
ROE
-1,489.05%
D/E
109.84
ROCE
-13.92%
Div. Yield
0.00%
EPS(TTM)
-0.53
Turnover
0.00
EV/EBITDA
-12.44
Net Margin
0.00%
Op. Margin
0.00%
ROA
-12.26%
Quick Ratio
0.00
Curr. Ratio
2.81
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
MPS Pharmaa outperforming all market indices
Step 1 of 5
Valuation
Overvalued
MPS Pharmaa appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,56,114.0037.645.4613.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,26,976.0077.6013.5415.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,89,990.0086.1122.0825.49%1.6913.85%222.760.68%0.4958.70
Cipla1,16,141.0034.333.3511.27%0.0014.95%423.360.91%0.4543.52
Zydus Lifesciences1,11,720.0024.334.1218.59%0.3117.35%237.300.09%0.3335.38
Lupin1,00,271.0018.064.4723.76%0.0424.88%659.050.82%0.57129.18
Dr. Reddy's Laboratories98,604.4030.812.5811.07%0.1812.54%377.960.68%0.4138.68
Mankind Pharma97,962.6047.386.0111.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs98,498.9089.9218.5016.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma94,087.0025.362.489.25%0.1911.76%391.140.25%0.3841.58

ADVIK LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.03
Other Income₹0.05₹0.09₹0.02₹0.26
Total Revenue₹0.05₹0.09₹0.02₹0.29
Total Expenses₹0.91₹0.95₹1.09₹1.22
Profit Before Tax-₹0.86-₹0.85-₹1.07-₹0.93
Tax₹0.03-₹0.02-₹0.02-₹0.79
Profit After Tax-₹0.90-₹0.83-₹1.05-₹0.14
EPS - Basic-₹0.47-₹0.43-₹0.55-₹0.07
EPS - Diluted-₹0.47-₹0.43-₹0.55-₹0.07

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.89-₹0.82-₹1.04-₹0.12
Income before WC changes-₹0.74-₹0.69-₹0.90-₹0.04
Change in Assets₹0.07-₹0.02-₹0.08₹0.17
Change in Liabilities₹0.10₹0.08₹0.12-₹4.47
Change in WC₹0.17₹0.06₹0.04-₹4.30
Cash flow from Operations-₹0.57-₹0.63-₹0.87-₹4.34
Cash flow from Investing₹0.38₹0.12-₹0.10₹0.46
Cash flow from Financing₹0.18₹0.51₹0.96₹3.88
Total Cash Flow₹0.00₹0.00-₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.01₹0.01₹0.01
Cash (End of the year)₹0.00₹0.01₹0.01₹0.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹7.28₹7.81₹8.08₹8.13
Current Assets₹2.05₹2.12₹2.10₹2.03
Total Assets₹9.33₹9.94₹10.19₹10.16
Current Liabilities₹8.07₹7.74₹7.17₹6.08
Net Current Asset-₹6.02-₹5.62-₹5.06-₹4.05
Non-Current Liabilities₹0.18₹0.22₹0.23₹0.25
Equity Capital₹1.08₹1.97₹2.79₹3.83
Total Equity & Liabilities₹9.33₹9.94₹10.19₹10.16
* All values are in INR Crore
Qty
Bid
2000
1.99
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 2000
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
100
Bullish
ATR (14)
0.03
Neutral
STOCH(9,6)
100
Bearish
ADX(9)
100
Bearish
ROC(12)
15.03
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
1.94
1.94
10D
1.87
1.88
20D
1.78
1.83
50D
1.91
0
100D
1.91
0
Volume trend — traded volume by day
17 Aug0L
Average0L
Compare against other stocks
ADVIK LABORATORIES LTD. Share Price
ADVIK LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

ADVIK LABORATORIES LTD. Share Price FAQs